Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Journal of Medicinal Chemistry
|
November 28, 2017
Highly Selective and Potent α4β2 nAChR Antagonist Inhibits Nicotine Self-Administration and Reinstatement in Rats
Jinhua Wu, Andrea Cippitelli, Yaohong Zhang, et al.
International Journal of Antimicrobial Agents
|
February 8, 2018
Identification of a small molecule inhibitor of the aminoglycoside 6'-N-acetyltransferase type Ib [AAC(6')-Ib] using mixture-based combinatorial libraries
Tung Tran, Kevin Chiem, Saumya Jani, et al.
Journal of Medicinal Chemistry
|
April 22, 2021
Discovery of Nanomolar Melanocortin-3 Receptor (MC3R)-Selective Small Molecule Pyrrolidine Bis-Cyclic Guanidine Agonist Compounds Via a High-Throughput "Unbiased" Screening Campaign
Skye R Doering, Katie Freeman, Ginamarie Debevec, et al.
Journal of Medicinal Chemistry
|
February 13, 2014
Identification of tetrapeptides from a mixture based positional scanning library that can restore nM full agonist function of the L106P, I69T, I102S, A219V, C271Y, and C271R human melanocortin-4 polymorphic receptors (hMC4Rs)
Erica M Haslach, Huisuo Huang, Marvin Dirain, et al.
Journal of Medicinal Chemistry
|
April 29, 2017
Discovery of Mixed Pharmacology Melanocortin-3 Agonists and Melanocortin-4 Receptor Tetrapeptide Antagonist Compounds (TACOs) Based on the Sequence Ac-Xaa<sup>1</sup>-Arg-(pI)DPhe-Xaa<sup>4</sup>-NH<sub>2</sub>
Skye R Doering, Katie T Freeman, Sathya M Schnell, et al.
ACS Chemical Biology
|
May 7, 2019
A Novel Class of Common Docking Domain Inhibitors That Prevent ERK2 Activation and Substrate Phosphorylation
Rachel M Sammons, Nicole A Perry, Yangmei Li, et al.
European Journal of Medicinal Chemistry
|
January 7, 2015
Synthesis and biological evaluations of novel endomorphin analogues containing α-hydroxy-β-phenylalanine (AHPBA) displaying mixed μ/δ opioid receptor agonist and δ opioid receptor antagonist activities
Miao Hu, Marc A Giulianotti, Jay P McLaughlin, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Journal of Medicinal Chemistry
|
November 28, 2017
Highly Selective and Potent α4β2 nAChR Antagonist Inhibits Nicotine Self-Administration and Reinstatement in Rats
Jinhua Wu, Andrea Cippitelli, Yaohong Zhang, et al.
International Journal of Antimicrobial Agents
|
February 8, 2018
Identification of a small molecule inhibitor of the aminoglycoside 6'-N-acetyltransferase type Ib [AAC(6')-Ib] using mixture-based combinatorial libraries
Tung Tran, Kevin Chiem, Saumya Jani, et al.
Journal of Medicinal Chemistry
|
April 22, 2021
Discovery of Nanomolar Melanocortin-3 Receptor (MC3R)-Selective Small Molecule Pyrrolidine Bis-Cyclic Guanidine Agonist Compounds Via a High-Throughput "Unbiased" Screening Campaign
Skye R Doering, Katie Freeman, Ginamarie Debevec, et al.
Journal of Medicinal Chemistry
|
February 13, 2014
Identification of tetrapeptides from a mixture based positional scanning library that can restore nM full agonist function of the L106P, I69T, I102S, A219V, C271Y, and C271R human melanocortin-4 polymorphic receptors (hMC4Rs)
Erica M Haslach, Huisuo Huang, Marvin Dirain, et al.
Journal of Medicinal Chemistry
|
April 29, 2017
Discovery of Mixed Pharmacology Melanocortin-3 Agonists and Melanocortin-4 Receptor Tetrapeptide Antagonist Compounds (TACOs) Based on the Sequence Ac-Xaa<sup>1</sup>-Arg-(pI)DPhe-Xaa<sup>4</sup>-NH<sub>2</sub>
Skye R Doering, Katie T Freeman, Sathya M Schnell, et al.
ACS Chemical Biology
|
May 7, 2019
A Novel Class of Common Docking Domain Inhibitors That Prevent ERK2 Activation and Substrate Phosphorylation
Rachel M Sammons, Nicole A Perry, Yangmei Li, et al.
European Journal of Medicinal Chemistry
|
January 7, 2015
Synthesis and biological evaluations of novel endomorphin analogues containing α-hydroxy-β-phenylalanine (AHPBA) displaying mixed μ/δ opioid receptor agonist and δ opioid receptor antagonist activities
Miao Hu, Marc A Giulianotti, Jay P McLaughlin, et al.
Page
of 2